25 
of which each article enters.” — Proc. Am. Pharm. Ass., 1905, v. 53, 
p. 260. 
Wilbert, M. I., calls attention to “ the main objects which a phy- 
sician usually has, or would have, for consulting a pharmacopoeia,” 
as defined by the late Charles Rice, and points out that in some very 
important respects the U. S. P., VIII, does not comply with these re- 
quirements. — Am. J. Pharm., Phila., 1905, v. 77, p. 355. 
A series of articles entitled “ The Pharmacopoeia and the Physi- 
cian ” includes a general review of the history of the Pharmacopoeia 
of the United States of America and its evolution, with some refer- 
ence to its scope and content. — J. Am. M. Ass., Chicago, 1905, v. 45, 
p. 1869 If. 
Bell, J. W. (St. Paul Med. J., August, 1905), expresses the hope 
that with the new pharmacopoeia and other factors now at work 
we may see the weak link in medicine, therapeutics, so strengthened in 
the near future as to commend itself alike to the public and to the 
skeptic within the profession. — Abstr. Ibid., p. 812. 
Marshall, C. R., would like to see more work done specialty for a 
pharmacopoeia and under the auspices of its authorities, and less 
dependence on outside and sporadic help. Everything in a pharma- 
copoeia should be put to the test by men well qualified and specialty 
appointed for the task, even if the work may have been done by others 
before. — Pharm. J. Bond., 1905, v. 21, p. 716. 
Lyons, A. B., says the National Formulary is a work that should be 
prepared with as much care as the pharmacopoeia. “ Elegant phar- 
macy ” has no place in the pharmacopoeia, and unless these prepara- 
tions are provided by some generally recognized authority physicians 
will be deprived of their use or driven to the manufacturers for such 
remedies as they are willing to prescribe. — Proc. Am. Pharm. Ass., 
1905, v. 53, p. 262. 
In an editorial review of the Spanish Pharmacopoeia it is pointed 
out that the revisers of that book have taken the position where the 
manufactured article is now universally and currently sold in a sat- 
isfactory state, the process may be omitted ; but where the laboratory 
preparation is simple and advantageous the formula should be given. 
In every case the leading characteristics and reagents for detecting 
adulterations should be given. — Brit. & Col. Druggist, Bond., 1905, 
v. 48, p. 480. 
Hinrichs, Carl G., discusses at some length the chemistry of the 
U. S. P., VIII. — Am. J. Pharm., Phila., 1905, v. 77, p. 503. 
3. SYNTHETICS. 
Hallberg, C. S. N., points out that “ the committee compromised 
by admitting such products for which the patent on the process or 
product, or both, expired or will expire before the end of the present 
